Fingerpaint Acquires MedThink

Fingerpaint Group Acquires The MYND Group

April 3, 2023

Healthcare Services

Fingerpaint Group has acquired The MYND Group, a strategic market access marketing firm serving pharmaceuticals and biologics; financial terms were not disclosed. The acquisition expands Fingerpaint's market access and managed markets capabilities and is the company's second market access buy in three years as it continues to scale under PE partnership with Knox Lane.

Fingerpaint Group Acquires PharmaHEALTHLabs

March 21, 2023

Healthcare Services

Fingerpaint Group has acquired PharmaHEALTHLabs, a specialized healthcare communications agency focused on oncology and biologics, and will rebrand it as Fingerpaint Medical Communications. The acquisition deepens Fingerpaint's medical and scientific communications capabilities as part of its Specialty Services offering; financial terms were not disclosed.

Fingerpaint Group Acquires L&M Healthcare Communications

November 11, 2025

Marketing & Advertising

Fingerpaint Group has acquired L&M Healthcare Communications, a New Jersey–based medical communications agency that serves biotech and pharmaceutical clients. The acquisition expands Fingerpaint Medical's medical communications and medical affairs capabilities; financial terms were not disclosed.

Fingerpaint Group Acquires Parsons Medical Communications

September 28, 2022

Marketing & Advertising

Fingerpaint Group, a Knox Lane–backed healthcare marketing and specialty services platform, has acquired Parsons Medical Communications (PMC), a boutique scientific communications firm focused on the eyecare segment. The acquisition expands Fingerpaint's medical communications and eyecare capabilities; financial terms and seller details were not disclosed.

Fingerpaint Acquires London-Based Data & Analytics Firm Engage

December 1, 2021

Data & Analytics

Fingerpaint, a global biopharma commercialization partner, has acquired Engage, a London-based data and analytics–enabled healthcare marketing firm, to strengthen its European footprint and data-driven capabilities. Financial terms were not disclosed; Engage's founders Mary McGregor and Dave Chandler will continue to lead day-to-day operations. Knox Lane, a San Francisco-based private equity firm, is a strategic investor in Fingerpaint.

Knox Lane Invests in Fingerpaint

December 1, 2020

Marketing & Advertising

Knox Lane, a San Francisco-based middle-market investment firm, has made a strategic growth investment in Fingerpaint, a full-service health and wellness marketing agency. Financial terms were not disclosed; Fingerpaint founder Ed Mitzen and the existing management team remain significant investors and will continue to lead the company as it pursues growth and capability expansion across its healthcare-focused marketing, analytics and market-access services.